These secondary markers often change before the scale moves, providing early confirmation that the drops are working
The FDA has raised concerns about the increased risk of dosing errors, improper storage and fraudulently labeled GLP-1s from compounding pharmacies
Potential Benefits of Microdosing GLP-1 RAs Reduced Side Effects: Lower doses minimize gastrointestinal discomfort, which can improve patient adherence and overall treatment tolerability
11,120 Knocking out or inhibiting the action of one or both of the incretin receptors results in some expected and unexpected phenotypes
A shortage of medication can be particularly concerning for people on GLP-1s considering that research shows that people who stop taking certain GLP-1s are likely to regain weight without the medication
Before Ozempic, you might have been eating 2,200 calories a day